Catalyst Pharmaceuticals Inc (CPRX)

R&D to Revenue

1.78%

Quarterly · Period ending:

CPRX logo

CPRX R&D to Revenue

Latest reported1.78%
CPRX Quarterly R&D/Revenue (0.00% → 1.78%)
High-resolution chart · PNG

CPRX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Catalyst Pharmaceuticals Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
1.7812%
1.184%
1.7905%
2.9735%
2.7485%
2.678%
2.5518%
2.4326%
2.6201%
1.7835%
81.472%
3.9706%
4.1726%
6.7367%
14.5168%
7.4991%
7.8976%
13.0309%
12.4798%
12.237%
9.9553%
13.4614%
12.7878%
14.6924%
14.4936%
20.9424%
14.8784%
16.0531%
26.5733%
1,683.3938%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
116.4043%
0%
0%
0%
0%
0%
0%
-770.8063%
0%
0%
0%
-602.492%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.